Market Overview

Janney Capital Initiates Coverage on BioMarin Pharmaceutical Inc. at Buy, Announces $60.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for BMRN

DateFirmActionFromTo
Oct 2017BMO CapitalMaintainsOutperform
Oct 2017Stifel NicolausMaintainsBuy
Oct 2017Leerink SwannMaintainsOutperform

View More Analyst Ratings for BMRN
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (BMRN)

Partner Center